Martin Gutierrez

8PUBLICATIONS
137CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 13, 2026
A Phase II Trial of an Extended-Release siRNA Implant Targeting KRASG12D/V in Locally Advanced Pancreatic Cancer.

Brinda Alagesan, Anna M Varghese, Celina Ang

|Aug 05, 2025
Phase 2 Study of Zilovertamab Vedotin in Participants with Metastatic Solid Tumors.

Funda Meric-Bernstam, Martin Gutierrez, Enrique Sanz-Garcia

|Jun 24, 2025
Combined Targeting of PD-1 and TIM-3 in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer: AMBER Part 2B.

Diwakar Davar, Zeynep Eroglu, Mohammed Milhem

|Dec 31, 2024
PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial.

Mark N Stein, Ecaterina E Dumbrava, Benjamin A Teply

|Aug 08, 2024
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study.

Justin F Gainor, Manish R Patel, Jeffrey S Weber

|Jun 04, 2024
Comprehensive Target Engagement by the EZH2 Inhibitor Tulmimetostat Allows for Targeting of ARID1A Mutant Cancers.

Patricia J Keller, Elizabeth J Adams, Rentian Wu

Pageof 2

Frequent Collaborators

1 joint publications

Ecaterina E Dumbrava

1 joint publications

Benjamin A Teply

1 joint publications

Ran Reshef

1 joint publications

Sumit K Subudhi